Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Comparing the Therapeutic Combinations Melarsoprol-Nifurtimox, Melarsoprol-Eflornithine and Eflornithine-Nifurtimox in the Treatment of Gambiense Human African Trypanosomiasis in the Meningo-Encephalitic Phase

NCT00330148 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT00330148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Comparing the Therapeutic Combinations Melarsoprol-Nifurtimox, Melarsoprol-Eflornithine and Eflornithine-Nifurtimox in the Treatment of Gambiense Human African Trypanosomiasis in the Meningo-Encephalitic Phase
Lead sponsor
Epicentre
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2001
Completion date
June 30, 2004
Enrollment
435
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trypanosomiasis, african